Back
Golub Capital BDC Vs. Apellis Pharmaceuticals Industry Stock Comparison
Sell
50
GBDC
Golub Capital BDC
Last Price:
14.88
Seasonality Move:
0.85%
Sell
19
APLS
Apellis Pharmaceuticals
Last Price:
32.49
Seasonality Move:
18.8%
Sell
50
Golub Capital BDC (GBDC)
is a Sell
Is Golub Capital BDC a Buy, Sell or Hold?
- The current Golub Capital BDC [GBDC] share price is $14.89. The Score for GBDC is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
- GBDC is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
19
Apellis Pharmaceuticals (APLS)
is a Sell
Is Apellis Pharmaceuticals a Buy, Sell or Hold?
- The current Apellis Pharmaceuticals [APLS] share price is $32.50. The Score for APLS is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
- APLS is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
GBDC Stock Price Chart
What is Golub Capital BDC's stock price today?
-
The Golub Capital BDC share price today is $14.89
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GBDC is experiencing slight buying pressure.
APLS Stock Price Chart
What is Apellis Pharmaceuticals's stock price today?
-
The Apellis Pharmaceuticals share price today is $32.50
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing slight selling pressure.
GBDC Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.01 | Sell |
Relative Strength Index (14 RSI): | 48.83 | Sell |
Chaikin Money Flow: | 198768 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (14.76 - 15.02) | Sell |
Bollinger Bands (100): | (14.86 - 16.3) | Sell |
APLS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.84 | Sell |
Relative Strength Index (14 RSI): | 33.6 | Sell |
Chaikin Money Flow: | -1084788 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (36.37 - 40.01) | Sell |
Bollinger Bands (100): | (36.55 - 42.35) | Sell |
GBDC Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 14.92 | Sell |
20-day SMA: | 14.91 | Sell |
50-day SMA: | 15 | Sell |
200-day SMA: | 15.67 | Sell |
8-day EMA: | 14.91 | Sell |
20-day EMA: | 14.9 | Sell |
50-day EMA: | 15.06 | Sell |
200-day EMA: | 15.35 | Sell |
APLS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 36.19 | Sell |
20-day SMA: | 38.04 | Sell |
50-day SMA: | 37.88 | Sell |
200-day SMA: | 50 | Sell |
8-day EMA: | 35.96 | Sell |
20-day EMA: | 37.21 | Sell |
50-day EMA: | 38.25 | Sell |
200-day EMA: | 45.7 | Sell |
Golub Capital BDC Earnings Growth & GBDC Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.01 per share, an increase this year of $0.21 per share, and a decrease next year of $0.18 per share.
Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.74 per share, an increase next quarter of $0.23 per share, an increase this year of $3.28 per share, and an increase next year of $1.34 per share.
Golub Capital BDC Technical Analysis
Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Apellis Pharmaceuticals Technical Analysis
Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |